BioSpace News Archive

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2023 and provides a business update.

Scientific Industries, Inc. announced it will file a Form 10Q after the close on May 15, 2023, for its first quarter financial results ended March 31, 2023, and issue a press release reporting its first quarter of 2023 before the market open on May 16, 2023.

The operation was led by the Botin Foundation Mind the Gap programme, with participation from BStartup of Banco Sabadell.

Ambrx Biopharma Inc., or Ambrx, announced that Daniel J. O’Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview at the JMP Securities Life Sciences Conference and RBC Capital Markets Global Healthcare Conference taking place in New York City on May 16th and 17th, respectively.

BIOLASE, Inc., the global leader in dental lasers, announced its financial results for the first quarter ended March 31, 2023.

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the quarter ended March 31, 2023.

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today reported financial results for the first quarter ended March 31, 2023.

Zomedica Corp., a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three months ended March 31, 2023.

Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.

Cidara Therapeutics, Inc. (NASDAQ: CDTX) today reported financial results for the first quarter ended March 31, 2023 and provided an update on its corporate activities and product pipeline.